Form 4: BlackRock Health Sciences Term Trust Portfolio Manager Increases Stake
SEC Form 4 Filing
Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Term Trust, recently purchased 1,190 shares of common stock at $15.17 per share.
Summary
- On January 11, 2024, Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Term Trust (BMEZ), acquired 1,190 shares of common stock.
- The purchase price was $15.17 per share.
- Following the transaction, Accettella directly owns 4,069.502 shares of BMEZ.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a portfolio manager is generally viewed as a positive sign, indicating confidence in the company's future performance, but the quantity is not significant.
Positives
- The purchase by a portfolio manager could be interpreted as a positive signal regarding their confidence in the fund's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to track confidence levels and potential alignment of interests.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/11/2024 | Date of stock purchase transaction |
| 10/04/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.